Figure 1
Maximum tumor size reduction from baseline. Includes patients with postbaseline CT assessments (n = 29). Five of the 34 evaluable patients did not have postbaseline imaging; all were determined to have clinical disease progression.
Maximum tumor size reduction from baseline. Includes patients with postbaseline CT assessments (n = 29). Five of the 34 evaluable patients did not have postbaseline imaging; all were determined to have clinical disease progression.
